Your browser doesn't support javascript.
loading
TCF1+PD-1+ tumour-infiltrating lymphocytes predict a favorable response and prolonged survival after immune checkpoint inhibitor therapy for non-small-cell lung cancer.
Koh, Jaemoon; Kim, Sehui; Woo, Yeon Duk; Song, Seung Geun; Yim, Jeemin; Han, Bogyeong; Lim, Sojung; Ahn, Hyun Kyung; Mun, Seungchan; Kim, Jung Sun; Keam, Bhumsuk; Kim, Young A; Lee, Se-Hoon; Jeon, Yoon Kyung; Chung, Doo Hyun.
Afiliación
  • Koh J; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Laboratory of Immune Regulation in Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim S; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Woo YD; Laboratory of Immune Regulation in Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Song SG; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Laboratory of Immune Regulation in Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yim J; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Han B; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lim S; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Ahn HK; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.
  • Mun S; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea; Interdiscipilinary Program of Cancer Biology, Seoul National University Graduate School, Seoul, Republic of Korea; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Republic of Ko
  • Kim JS; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Keam B; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim YA; Department of Pathology, Seoul Metropolitan Government Boramae Hospital, Seoul, Republic of Korea.
  • Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic
  • Jeon YK; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea; Interdiscipilinary Program of Cancer Biology, Seoul National University Graduate School, Seoul, Republic of Korea; Integra
  • Chung DH; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea; Laboratory of Immune Regulation in Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: doohyun@snu.ac.kr.
Eur J Cancer ; 174: 10-20, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35970031
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido